These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 20034226)

  • 1. [Preparation and drug release property of paclitaxel nanoparticles].
    Wang TW; Wu Y; Li MJ; Gao HX
    Zhong Yao Cai; 2009 Sep; 32(9):1447-9. PubMed ID: 20034226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy.
    Dong Y; Feng SS
    Int J Pharm; 2007 Sep; 342(1-2):208-14. PubMed ID: 17560058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions.
    Xu J; Ma L; Liu Y; Xu F; Nie J; Ma G
    Int J Biol Macromol; 2012 Mar; 50(2):438-43. PubMed ID: 22230611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
    Abouelmagd SA; Ku YJ; Yeo Y
    J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel.
    Xie J; Wang CH
    Pharm Res; 2005 Dec; 22(12):2079-90. PubMed ID: 16132339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionically fixed polymeric nanoparticles as a novel drug carrier.
    Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
    Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
    Lundberg BB
    Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro.
    Jin C; Bai L; Wu H; Tian F; Guo G
    Biomaterials; 2007 Sep; 28(25):3724-30. PubMed ID: 17509678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.
    Bansal A; Kapoor DN; Kapil R; Chhabra N; Dhawan S
    Acta Pharm; 2011 Jun; 61(2):141-56. PubMed ID: 21684843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and in-vitro bioactivity evaluation of paclitaxel-loaded polyester nanoparticles.
    López-Gasco P; Iglesias I; Benedí J; Lozano R; Blanco MD
    Anticancer Drugs; 2012 Oct; 23(9):947-58. PubMed ID: 22713593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of paclitaxel.
    Kollipara S; Bende G; Movva S; Saha R
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1377-87. PubMed ID: 20545520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of magnetic solid liposome nanoparticles of paclitaxel].
    Xin SC; Wu XR; Zhou LZ
    Yao Xue Xue Bao; 2006 Oct; 41(10):933-8. PubMed ID: 17184109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.